Texas 2021 - 87th Regular

Texas Senate Bill SB1997

Caption

Relating to the control of diseases of swine.

Impact

The implementation of SB1997 is expected to significantly strengthen the state's response to swine disease outbreaks by clarifying the roles of agricultural representatives in disease control. By tightening regulations around the sale and distribution of classical swine fever virus, the bill could prevent unauthorized access to dangerous pathogens, thus safeguarding the health of both livestock and humans. It reflects a proactive approach in the face of the potential economic implications of swine disease outbreaks, which can adversely affect the farming industry and related agricultural markets within Texas.

Summary

SB1997 addresses the control and eradication of diseases affecting swine, notably classical swine fever, also known as hog cholera. The legislation amends the Agriculture Code to enhance the authority and procedures for the vaccination and treatment of swine in response to disease outbreaks. Notably, it includes provisions to cooperate with the United States Department of Agriculture on disease eradication efforts and facilitates tougher rules for disease management through the Texas commission responsible for animal health. The bill aims to streamline procedures that can be enacted when dealing with swine diseases to protect public health and the agricultural sector's economic viability.

Sentiment

The general sentiment towards SB1997 appears to be supportive from both farmers and agricultural organizations that prioritize animal health. Entities such as farmers' associations have expressed their backing, viewing the bill as a crucial measure to mitigate the risks posed by swine diseases. However, some skepticism arises from critics who argue that the stringent controls over viral distribution could complicate research and development efforts in veterinary medicine, potentially hindering advancements in swine health management in the long run.

Contention

A notable point of contention regarding SB1997 centers on the balance between strict regulatory controls and the need for research flexibility. While the aims of SB1997 to control swine diseases are well-received, there are concerns that overly stringent regulations might limit the ability of research institutions to explore innovative treatments or vaccines. This tension between regulation and innovation highlights the need for ongoing dialogue among stakeholders in the agricultural and scientific communities to ensure that disease management efforts support public health without stifling scientific progress.

Companion Bills

TX HB3855

Same As Relating to the control of diseases of swine.

Previously Filed As

TX HB5029

Relating to imposing a surcharge on certain electric generators and gas producers.

TX HB1403

Relating to the establishment by certain counties and hospital districts of disease control pilot programs to reduce the risk of certain infectious and communicable diseases; authorizing fees.

TX HB1593

Relating to infection prevention and control programs and other measures for communicable diseases at certain long-term care facilities; authorizing an administrative penalty.

TX HB4955

Relating to imposing a tax on the generation of electricity by certain electric generators to provide revenue for property tax relief.

TX SB488

Relating to imposing a tax on the generation of electricity by certain electric generators to provide revenue for property tax relief.

TX HB3378

Relating to the promotion of breast-feeding and the prohibition against interference with or restriction of the right to breast-feed; creating a civil action.

TX SB403

Relating to a study on the adverse reactions and efficacy of COVID-19 vaccines.

TX HB181

Relating to the establishment of the sickle cell disease registry.

TX SB306

Relating to the right to choose medical treatments and certain control measures and to the imposition of isolation or quarantine control measures.

TX HB1313

Relating to a study on the side effects, adverse reactions, including death, and the effectiveness of vaccines against the SARS-CoV-2 virus (COVID-19) or its variants.

Similar Bills

No similar bills found.